Cancer drug mechanism prediction is an AI model developed by National Cancer Institute (United States), first published in October 1992. It works in the medicine domain, on tasks such as drug discovery.
Training it took an estimated 5.3×10⁷ FLOP of compute (estimation method: operation counting). The model has 594 parameters. It was trained on roughly 141 datapoints.
Epoch AI rates the confidence of this record as likely.